Which antibiotics are recommended for treating bacterial prostatitis, seminal‑vesiculitis, and pyospermia?

Antimicrobial Therapy for Bacterial Prostatitis, Seminal Vesiculitis, and Pyospermia

For acute bacterial prostatitis, ciprofloxacin 500–750 mg orally twice daily for 2–4 weeks is the first-line choice when local fluoroquinolone resistance is below 10%, with ceftriaxone 1–2 g IV once daily reserved for severe cases requiring hospitalization. 1

Acute Bacterial Prostatitis

First-Line Oral Therapy (Mild-to-Moderate Cases)

• Ciprofloxacin 500–750 mg orally twice daily for 2–4 weeks is recommended when local fluoroquinolone resistance rates are <10%. 1
• Levofloxacin 750 mg orally once daily represents an alternative fluoroquinolone option with similar efficacy. 1
• Avoid fluoroquinolones if local resistance exceeds 10% or if the patient received them within the preceding 6 months. 2

Parenteral Therapy (Severe Cases, Hospitalization)

• Ceftriaxone 1–2 g IV once daily or cefotaxime 2 g IV three times daily are first-choice parenteral agents for patients with fever, systemic toxicity, or inability to tolerate oral medications. 1, 2
• Ciprofloxacin 400 mg IV twice daily can be used parenterally, with transition to oral therapy once clinical improvement occurs (typically 48–72 hours). 1, 2
• Piperacillin-tazobactam 2.5–4.5 g IV three times daily provides broad-spectrum coverage including enterococci. 1
• Amikacin is a second-choice option for severe prostatitis, particularly when multidrug-resistant organisms are suspected. 1

Healthcare-Associated Infections

• For healthcare-associated infections with suspected enterococci or multidrug-resistant organisms, consider ampicillin, piperacillin-tazobactam, or vancomycin based on susceptibility patterns. 2
• Reserve carbapenems or novel broad-spectrum agents only when early culture results confirm multidrug-resistant pathogens. 1, 2

Critical Pitfalls

• Avoid prostatic massage or vigorous digital rectal examination in acute bacterial prostatitis due to risk of bacteremia and sepsis. 2
• Do not use amoxicillin, ampicillin, or trimethoprim-sulfamethoxazole empirically due to high worldwide resistance rates. 2
• Stopping antibiotics prematurely can lead to chronic bacterial prostatitis; complete the full 2–4 week course. 2

Chronic Bacterial Prostatitis

Standard Therapy

• The same fluoroquinolone regimens used for acute prostatitis apply, but treatment duration extends to 4–12 weeks to prevent relapse. 2
• Ciprofloxacin 500–750 mg orally twice daily or levofloxacin 750 mg orally once daily for 4–12 weeks are preferred when local resistance is <10%. 1, 2

Atypical Pathogens (Chlamydia, Mycoplasma, Ureaplasma)

• Test for atypical pathogens including Chlamydia trachomatis and Mycoplasma species using the Meares-Stamey 2- or 4-glass test, which shows a 10-fold higher bacterial count in expressed prostatic secretions versus midstream urine. 1, 2
• Azithromycin 1 g orally as a single dose or doxycycline 100 mg orally twice daily for 7 days effectively treats chlamydial and mycoplasmal prostatitis. 1
• For ureaplasmal prostatitis (20–40% of nongonococcal urethritis cases), doxycycline 100 mg orally twice daily for 7 days is recommended. 1
• If tetracycline-resistant Ureaplasma urealyticum is suspected after doxycycline failure, switch to erythromycin base 500 mg orally four times daily for 14 days. 1

Young Men (<35 Years) with Sexual Risk Factors

• Add doxycycline 100 mg orally twice daily for 7 days to the fluoroquinolone regimen to cover Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma species. 2
• Alternatively, use azithromycin 1 g orally as a single dose for Mycoplasma coverage. 2

Seminal Vesiculitis

Empiric Therapy

• Ciprofloxacin 500 mg orally as a single dose has demonstrated efficacy in treating seminal vesiculitis with considerable improvement in seminal vesicle function. 3
• For chronic bacterial seminal vesiculitis, levofloxacin 500 mg orally daily for 14 consecutive days per month for 3 months achieves bacterial eradication in approximately 71% of cases. 4

Diagnostic Considerations

• Semen culture has 97% sensitivity for Gram-negative organisms and 100% sensitivity for Gram-positive organisms, superior to expressed prostatic secretion cultures (82.4% and 16.1% respectively). 5
• First-void urine and semen culture are the only tests necessary to diagnose chronic bacterial prostatitis and seminal vesiculitis. 5

Pyospermia (Leukocytospermia)

Treatment Based on Underlying Etiology

• When pyospermia is associated with chronic bacterial prostatitis, levofloxacin 500 mg orally daily for 14 days per month for 3 months significantly decreases seminal leukocyte count, improves sperm progressive motility, and reduces seminal fluid viscosity in responders (bacterial eradication to <10³ CFU/mL). 4
• Successful antibiotic therapy leads to significant reduction in reactive oxygen species production, tumor necrosis factor-α, and interleukin-6 levels in seminal fluid. 4

Poor Responders

• Approximately 29% of patients show poor antibiotic responsiveness (bacterial count >10³ to <10⁵ CFU/mL after treatment), with deterioration of sperm parameters and persistent inflammation. 4
• These patients require extended therapy or alternative antimicrobial strategies based on culture and sensitivity results. 4

Epididymitis-Associated Prostatitis

Men <35 Years (Sexually Transmitted Etiology)

• Ceftriaxone 250–1000 mg IM/IV once plus doxycycline 100 mg orally twice daily for 10 days covers both N. gonorrhoeae (ceftriaxone) and C. trachomatis (doxycycline). 6, 1, 7
• For men who have sex with men with acute proctitis and prostatitis, use ceftriaxone 250 mg IM single dose plus doxycycline 100 mg orally twice daily for 7 days. 1
• If lymphogranuloma venereum is suspected, extend doxycycline to 100 mg orally twice daily for 3 weeks. 1

Men ≥35 Years (Enteric Organism Etiology)

• Ofloxacin 300 mg orally twice daily for 10 days or levofloxacin 500 mg orally once daily for 10 days provides effective coverage of enteric Gram-negative pathogens with excellent tissue penetration. 6, 7

Allergy-Adjusted Regimens

• For patients allergic to cephalosporins or tetracyclines, ofloxacin 300 mg orally twice daily for 10 days covers both gonorrhea and chlamydia, though rising fluoroquinolone-resistant N. gonorrhoeae limits its use. 6, 7

Monitoring and Follow-Up

• Reassess clinical response after 48–72 hours of treatment; failure to improve requires reevaluation of diagnosis and therapy. 6, 2, 7
• Monitor for progression to urosepsis, which occurs in 7.3% of severe genitourinary infections, by checking vital signs, lactate, complete blood count, and obtaining blood cultures as indicated. 1, 2, 7
• Swelling and tenderness persisting after antimicrobial completion warrant comprehensive evaluation for tumor, abscess, infarction, testicular cancer, or tuberculous/fungal infection. 6

Partner Management

• All sexual partners within the preceding 60 days should be evaluated and treated empirically. 6, 7
• Patients must abstain from sexual intercourse until both they and their partners complete therapy and are asymptomatic. 6, 7